International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Pharmacokinetics

Pharmacokinetics


As per available reports about 57 relevant Journals, 50 Conferences,10 Workshops are presently dedicated exclusively to pharmacokinetics and about   3058 articles are being published on pharmacokinetics.

Pharmacokinetics is a fundamental scientific discipline that underpins applied therapeutics. Patients need to be prescribed appropriate medicines for a clinical condition. The medicine is chosen on the basis of an evidence based approach to clinical practice and assured to be compatible with any other medicines or alternative therapies the patient may be taking. Pharmacokinetics, sometimes described as what the body does to a drug, refers to the movement of drug into, through, and out of the body—the time course of its absorption (see Drug Absorption), bioavailability (see Drug Bioavailability), distribution (see Drug Distribution to Tissues), metabolism (see Drug Metabolism), and excretion (see Drug Excretion).

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

Pharmacokinetics Conference provides the scope for opportunities to learn progressed by international scientists and academicians. Pharmacokinetics  can be considered to be one aspect of that provides a link to the performance of the drug product used in clinical trials and to the database containing evidence of safety and efficacy. Drug pharmacokinetics determines the onset, duration, and intensity of a drug’s effect. Formulas relating these processes summarize the pharmacokinetic behavior of most drugs.

The design of a dosage regimen is dependent on a basic understanding of the drug use process (DUP). When faced with a patient who shows specific clinical signs and symptoms, pharmacists must always ask a fundamental question: ‘Is this patient suffering from a drug-related problem?’ Once this issue is evaluated and a clinical diagnosis is available, the pharmacist can apply the DUP to ensure that the patient is prescribed an appropriate medication regimen, that the patient understands the therapy prescribed, and that an agreed concordance plan is achieved.

Once a particular medicine is chosen, the principles of clinical pharmacokinetics are required to ensure the appropriate formulation of drug is chosen for an appropriate route of administration. On the basis of the patient’s drug handling parameters, which require an understanding of absorption, distribution, metabolism and excretion, the dosage regimen for the medicine in a particular patient can be developed. The pharmacist will then need to ensure that the appropriate regimen is prescribed to achieve optimal efficacy and minimal toxicity. Pharmacists then ensure that the appropriate monitoring is undertaken and that the patient receives the appropriate information to ensure compliance. Clinical pharmacokinetics  is thus a fundamental knowledge base that pharmacists require  to ensure effective practice of pharmaceutical care.

Market Analysis:

The global market on pharmacokinetics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.

List of Best International Conferences:

  1. 7th Bioavailability and Bioequivalence: BA/BE Studies Summit
    August 29-31, 2016 Atlanta, USA
  2. 8th  Pharmaceutics and Novel Drug Delivery Systems Conference 
    March 07-09, 2016 Madrid, Spain
  3. Industrial Pharmacy Conference
    April 28-29, 2016 Dubai, UAE
  4. 5th Global Pharmacovigilance Summit 
    April 25-27, 2016 Dubai, UAE
  5. Medical Writing and Healthcare Communications Conference
    April 28-29, 2016 Dubai, UAE
  6. 2nd Pharmacology and Ethnopharmacology Conference
    May 02-04, 2016 Chicago, USA
  7. 4th European Pharma Congress
    June 13-15, 2016 Berlin, Germany
  8. American Pharma Expo
    June 20-22,2016 New Orleans, USA
  9. 7th Annual Pharma Summit
    June 20-22, 2016 New Orleans, USA
  10. 6th Pharmacovigilance Conference Congress
    August 01-03, 2016 Toronto, Canada
  11. 3rd World Congress on Pharmacology
    August 08-10, 2016 Birmingham, UK
  12. 2nd Clinical Trials Conference 
    August 22-24, 2016 Philadelphia, USA
  13. 2nd Drug Discovery Designing Conference 
    Oct 31-Nov 02, 2016 Istanbul, Turkey
  14. ICPSP 2016: 18th International Conference on Pharmaceutical Sciences and Pharmacology Jan 21-22,2016 Paris, France
  15. 29th Annual Pharmacokinetics for Pharmaceutical Scientist 29 Feb – 4 March 2016 San Francisco, CA
  16. JP Morgan Annual Healthcare Conference January, 2016
  17. ASCPT Annual Meeting San Diego, CA Mar 8-12, 2016  
  18. 29th Orphan Drugs, Collaborations and Market Access Congress San Diego, United States of America
  19. 11th Drug Discovery India 2014 Mumbai, India
  20. 27th Re-Entering Antibacterial Drug Development Summit Boston, United States of America

Associations

  • Bioanalytical Focus Group and Ligand Binding Assay
  • American Association of Pharmaceutical Scientists (AAPS)
  • Royal Netherlands Chemical Society
  • The European Bioanalysis Forum
  • BEBAC Consultancy Services for Bioequivalence and Bioavailability
  • American Thyroid Association
  • Generic Pharmaceutical Association
  • FDA
  • European Generic medicines Association.
  • Therapeutics Goods Administration (TGA)
  • European Economic Area
  • Canadian Generic Pharmaceutical Association (CGPA)
  • Bioequivalence and Bioavailability forum
  • National Center for Biotechnology Information
  • U.S. National Library of Medicine
  • American Society for Clinical Pharmacology and Therapeutics
  • American Society of Clinical Oncology (ASCO)
  • Association of intratumoral pharmacokinetics of fluorouracil with clinical response
  • Central Los Angeles Community Clinical Oncology Program Los Angeles, California, U.S.A
  • British Pharmacological Society
  • American Association of Pharmaceutical Scientists Sections and Focus Groups
  • Population pharmacokinetics (PK) and association of PK and clinical outcomes of rituximab in   patients with non-Hodgkin's lymphoma

Companies :

  • Myriad RBM, Inc
  • NDI ADRL Inc. dba Diteba
  • BioScience Laboratories, Inc.
  • Pacific BioLabs (PBL)
  • Biological Test Center
  • Algorithme Pharma, Inc.
  • Gateway Analytical
  • Celerion
  • Apotex Inc.
  • PharmaNet Development Group, Inc
  • AstraZeneca
  • Accredo Therapeutics
  • Actelion Pharmaceuticals US, Inc
  • Bayer HealthCare
  • CRITICAL CARE
  • Cané Medical Technology
  • CVS Caremark
  • CuraScript
  • Fairview Specialty Pharmacy
  • Gilead Sciences
  • Vivisol
  • AIM
  • Henry Schein
  • Snap Diagnostics
  • MediLexicon
  • Nicos Group Inc.
  • Bausch & Lomb Instruments
  • JEDMED
  • Miami Medical
  • Image Stream Medical

 

This page will be updated regularly.

This page was last updated on April 26, 2024

Conference Series Destinations